Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC.
Careful assessment of the bleeding history is the first step in the evaluation of patients with mild/moderate bleeding disorders, and the use of a bleeding assessment tool (BAT) is strongly encouraged. Although a few studies have assessed the utility of the ISTH-BAT in patients with inherited platelet function disorders (IPFD) none of them was sufficiently large to draw conclusions and/or included appropriate control groups. Aim of the present study was to test the utility of the ISTH-BAT in a large cohort of patients with a well-defined diagnosis of inherited platelet disorder in comparison with two parallel cohorts, one of patients with type-1 VWD (VWD-1) and one of healthy controls (HC). We enrolled 1098 subjects, 482 of whom with inherited platelet disorders [196 IPFD and 286 inherited platelet number disorders (IT)] from 17 countries. IPFD patients had significantly higher bleeding score (BS) (median 9) than VWD-1 patients (median 5), a higher number of hemorrhagic symptoms (4 vs 3) and higher percentage of patients with clinically relevant symptoms (score >2). The ISTH-BAT showed excellent discrimination power between IPFD and HC (0.9<AUC<1), moderate (0.7<AUC<0.9) between IPFD and VWD-1 and between IPFD and inherited thrombocytopenia (IT), while it is inaccurate (AUC≤0.7) in discriminating IT from HC. in conclusion, the ISTH-BAT allows to efficiently discriminate IPFD from HC, while it has lower accuracy in distinguishing IPFD from VWD-1. Therefore, the ISTH-BAT appears useful to identify subjects requiring laboratory evaluation for a suspected IPFD once VWD is preliminarily excluded.